Brief: Revelation Biosciences Initiates Phase 1B Study Of Allergic Rhinitis And Chronic Nasal Congestion Treatment
15/11/2021 14:19
Nov 15 (Reuters) - Petra Acquisition Inc PAIC.O :
* REVELATION BIOSCIENCES INC. ANNOUNCES INITIATION OF A
PHASE 1B
CLINICAL STUDY OF REVTX-99 FOR THE EXPERIMENTAL TREATMENT OF
ALLERGIC RHINITIS AND CHRONIC NASAL CONGESTION
Source text for Eikon: ID:nGNX7H64Hc
Further company coverage: PAIC.O
((Reuters.Briefs@thomsonreuters.com;))